Purchase this article with an account.
F.Y. Chien, E.E. Manche; Wavefront–Guided LASIK for the Treatment of Consecutive Hyperopia . Invest. Ophthalmol. Vis. Sci. 2006;47(13):534.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate the efficacy, predictability, and safety of hyperopic wavefront–guided LASIK using the Visx CustomVue excimer laser in eyes following LASIK.
This retrospective analysis comprised of 10 eyes of 9 patients that had hyperopic wavefront–guided LASIK for consecutive hyperopia and hyperopic astigmatism following their initial LASIK surgery. Primary outcome variables including uncorrected visual acuity (UCVA), best spectacle– corrected visual acuity (BSCVA), higher order aberrations and spherical equivalence were evaluated at 1 month.
The mean spherical equivalence was +0.9 diopters (D) +/– 0.41 (SD) (range +0.25 to 1.5 D) preoperatively and –0.21 +/– 0.66 D (range –1.25 to 0.63 D) at 1 month. At 1 month, 40% of eyes had an UCVA of 20/20 or better and 70% of eyes had an UCVA of 20/25 or better, and 80% had an UCVA of 20/40 or better; 60% of eyes were within +/–0.5 D of emmetropia and 80% were within +/–1.0 D of emmetropia. No eyes lost more than 2 lines of vision.
Hyperopic wavefront–guided LASIK is an effective, predictable, and safe procedure for consecutive hyperopia and hyperopic astigmatism following LASIK. Results at 3 months and 6 months will be presented.
This PDF is available to Subscribers Only